- 全部删除
您的购物车当前为空
HS-276 是一种高度选择性的、口服具有活力的 TAK1 抑制剂 (Ki: 2.5 nM)。HS-276 能够显著抑制 TAK1 (IC50: 8.25 nM)、CLK2 (IC50: 29 nM)、GCK (IC50: 22 nM)、ULK2 (IC50: 63 nM)、MAP4K5 (IC50: 125 nM)、IRAK1 (IC50: 264 nM)、NUAK (IC50: 270 nM)、CSNK1G2 (IC50: 810 nM)、CAMKKβ-1 (IC50: 1280 nM) 和 MLK1 (IC50: 5585 nM)。HS-276 能够用于研究类风湿关节炎 (RA)。


为众多的药物研发团队赋能,
让新药发现更简单!
HS-276 是一种高度选择性的、口服具有活力的 TAK1 抑制剂 (Ki: 2.5 nM)。HS-276 能够显著抑制 TAK1 (IC50: 8.25 nM)、CLK2 (IC50: 29 nM)、GCK (IC50: 22 nM)、ULK2 (IC50: 63 nM)、MAP4K5 (IC50: 125 nM)、IRAK1 (IC50: 264 nM)、NUAK (IC50: 270 nM)、CSNK1G2 (IC50: 810 nM)、CAMKKβ-1 (IC50: 1280 nM) 和 MLK1 (IC50: 5585 nM)。HS-276 能够用于研究类风湿关节炎 (RA)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 596 | In stock | |
| 5 mg | ¥ 1,490 | In stock | |
| 10 mg | ¥ 2,320 | In stock | |
| 25 mg | ¥ 3,970 | In stock | |
| 50 mg | ¥ 5,670 | In stock | |
| 100 mg | ¥ 7,880 | In stock | |
| 200 mg | ¥ 10,600 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,630 | In stock |
HS-276 相关产品
| 产品描述 | HS-276 is a highly selective, orally active inhibitor of TAK1 (Ki: 2.5 nM). HS-276 significantly inhibits TAK1 (IC50: 8.25 nM), CLK2 (IC50: 29 nM), GCK (IC50: 22 nM), ULK2 (IC50: 63 nM), MAP4K5 (IC50. HS-276 can be used to study rheumatoid arthritis (RA). |
| 靶点活性 | CaMKK β1:1280 nM, CSNK1G2:810 nM, IRAK4:2500 nM, TAK1:2.5 nM (Ki), GCK:33 nM, TAK1:8.25 nM, IRAK1:264 nM, MAP4K5:125 nM, MLK1:5585 nM, NUAK:270 nM, CLK2:29 nM, ULK2:63 nM |
| 分子量 | 419.52 |
| 分子式 | C24H29N5O2 |
| CAS No. | 2767422-72-8 |
| Smiles | C(CC)N1C=2C(N=C1NC(=O)C3=CC(C(N)=O)=CC=C3)=CC=C(CN4CCCCC4)C2 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45.0 mg/mL (107.3 mM), when pH is adjusted to 2 with HCl. Sonication and heating to 80℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容